- Dexcom Announces Upcoming Conference Presentations
- DexCom Promotes Jake Leach to Chief Operating Officer
- Dexcom Announces Upcoming Conference Presentation
- Dexcom ONE real-time Continuous Glucose Monitoring (rt-CGM) System available on prescription in the UK, improving access to rt-CGM for people with diabetes
- Dexcom Reports Second Quarter 2022 Financial Results
- Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish
- Dexcom Canada Achieves Great Place to Work® Certification
- Dexcom Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022 at 4:30 p.m. Eastern Time.
As of last trade,
Dexcom Inc (DC4X:GER) traded at 81.84, 27.56% above the 52 week low of 64.16 set on Jun 16, 2022.
64.16Jun 16 2022145.65Nov 17 2021
Markit short selling activity
|Market cap||31.67bn USD|
|EPS (TTM)||0.4741 |
Data delayed at least 15 minutes, as of Sep 23 2022 16:35 BST.